Terms: = Breast cancer AND EXT2, Q93063, ENSG00000151348, 2132, SOTV AND Diagnosis
5 results:
1. Estimating the incidence of breast cancer recurrence using administrative data.
Habbous S; Barisic A; Homenauth E; Kandasamy S; Forster K; Eisen A; Holloway C
Breast Cancer Res Treat; 2023 Apr; 198(3):509-522. PubMed ID: 36422755
[TBL] [Abstract] [Full Text] [Related]
2. Screening and predicted value of potential biomarkers for breast cancer using bioinformatics analysis.
Zeng X; Shi G; He Q; Zhu P
Sci Rep; 2021 Oct; 11(1):20799. PubMed ID: 34675265
[TBL] [Abstract] [Full Text] [Related]
3. Economic impact of avoidable cancer deaths caused by diagnostic delay during the COVID-19 pandemic: A national population-based modelling study in England, UK.
Gheorghe A; Maringe C; Spice J; Purushotham A; Chalkidou K; Rachet B; Sullivan R; Aggarwal A
Eur J Cancer; 2021 Jul; 152():233-242. PubMed ID: 34049776
[TBL] [Abstract] [Full Text] [Related]
4. Analysis of a RECQL splicing mutation, c.1667_1667+3delAGTA, in breast cancer patients and controls from Central Europe.
Bogdanova N; Pfeifer K; Schürmann P; Antonenkova N; Siggelkow W; Christiansen H; Hillemanns P; Park-Simon TW; Dörk T
Fam Cancer; 2017 Apr; 16(2):181-186. PubMed ID: 27832498
[TBL] [Abstract] [Full Text] [Related]
5. [Analysis of the breast cancer survival in a public hospital during the period 1999-2008].
Colina Ruizdelgado F; Pilas Pérez M; Lora Pablos D
Rev Esp Salud Publica; 2012 Dec; 86(6):589-600. PubMed ID: 23325134
[TBL] [Abstract] [Full Text] [Related]
